• 

  Updates on Alzheimer’s Drug Research from AAIC 2024
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.02)
• 

  Kisunla for Alzheimer’s: A Trial Participant’s Inside Story
• 

  Alzheimer’s Drug Trial Drama: Cassava CEO Resigns After News of Federal Probe
• 

  Wish the World of Alzheimer’s Clinical Trials Was Easier to Understand?
• 

  Why Brain Banks Are Goldmines for Brain Disease Research
• 

  Pros and Cons: 4 Patients Open Up About Participating in Alzheimer’s Clinical Trials
• 

  Considering Enrolling in a Dementia Clinical Trial? 6 Things You Should Know
• 

  How Do Alzheimer’s Clinical Trials Work? And Other FAQs
• 

  Former Cassava Advisor Indicted for Fraud, 2 Senior Employees Under Investigation
• 

  How to Read News Articles About Dementia — And Spot Hype and Exaggeration
• 

  ‘A Time of Hope’: Experts on Alzheimer’s Drug Breakthroughs
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.01)
• 

  An Army Vet’s 23&Me Test Inspired Him to Join a Clinical Trial. There, He Learned He Had Early Signs of Alzheimer’s
• 

  Black Americans Have 2x the Alzheimer’s Risk—But They’re Underrepresented in Drug Trials

Previous234Next